Butterfly Medical Gains CE Mark for Benign Prostatic Hyperplasia Therapeutic Device

Butterfly Medical has received a CE mark for its device used to reduce or eliminate symptoms of benign prostatic hyperplasia.

The device consists of an anatomically shaped nitinol implant that is positioned in the urethra in order to open the urine path in the prostate for improved urine flow.  

Available in multiple sizes, the implant does not require any resection, cutting or ablation of prostatic tissue, the company said.